Cited by 1,280Cancer-related Molecular PathwaysDevelopmental Biology and Gene RegulationCell death mechanisms and regulation

The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.

Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53

Jones, Stephen N., Roe, Amy E., Donehower, Lawrence A., Bradley, Allan·1995·Nature

DOI 10.1038/378206a0

Open this paper in CoChat — free account

Abstract

The Mdm2 proto-oncogene was originally identified as one of several genes contained on a mouse double minute chromosome present in a transformed derivative of 3T3 cells. Overexpression of Mdm2 can immortalize primary cultures of rodent fibroblasts. Human MDM2 is amplified in 30-40% of sarcomas, and is overexpressed in leukaemic cells. The Mdm2 oncoprotein forms a complex with the p53 tumour-suppressor protein and inhibits p53-mediated transregulation of gene expression. Because Mdm2 expression increases in response to p53, Mdm2-p53 binding may autoregulate Mdm2 expression and modulate the activity of p53 in the cell. We have created Mdm2-null and Mdm2/p53-null mice to determine whether Mdm2 possesses developmental functions in addition to the ability to complex with p53, and to investigate the biological role of Mdm2-p53 complex formation in development. Mice deficient for Mdm2 die early in development. In contrast, mice deficient for both Mdm2 and p53 develop normally and are viable. These results suggest that a critical role of Mdm2 in development is the regulation of p53 function.

Integrity signals

Registry

Crossref · 10.1038/378206a0

Cites

24 of 24 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Self-citation
Participation of p53 protein in the cellular response to DNA damage.
Kastan, M. B., Onyekwere, O. C., Sidransky, D., Vogelstein, B., & Craig, R. W. (1991) · PubMed · Cited by 3,761
The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
Amplification of a gene encoding a p53-associated protein in human sarcomas
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L., & Vogelstein, B. (1992) · Nature · doi:10.1038/358080a0 · Cited by 1,949
The p53-mdm-2 autoregulatory feedback loop.
Wu, X., Bayle, J. H., Olson, D., & Levine, A. J. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1126 · Cited by 1,801
The Atlas of Mouse Development
Kaufman, M. H. (1992) · Medical Entomology and Zoology · Cited by 1,750
Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: A general strategy for targeting mutations to non-selectable genes
Mansour, S. L., Thomas, K. R., & Capecchi, M. R. (1988) · Nature · doi:10.1038/336348a0 · Cited by 1,683
The atlas of mouse development
Beddington, R. S. P. (1993) · Trends in Genetics · doi:10.1016/0168-9525(93)90071-o · Cited by 1,416
α-lnhibin is a tumour-suppressor gene with gonadal specificity in mice
Matzuk, M. M., Finegold, M. J., Su, J.-G. J., Hsueh, A. J. W., & Bradley, A. (1992) · Nature · doi:10.1038/360313a0 · Cited by 893
Self-citation

Flagged first, then by citations

Show all 24 references

Research works printed but not linked: 5

Juven, T., Barak, Y., Zauberman, A., George, D. & Oren, M. Oncogene 8, 3411–3416 (1993).
Snow, M. H. L. J. Embryol. exp. Morph. 42, 293–303 (1977).
Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V. & Vogelstein, B. Science 253, 49–53 (1990).
Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B. & Craig, R. W. Cancer Res. 51, 6304–6311 (1991).
Olson, D. C. et al. Oncogene 8, 2353–2360 (1993).

Sorted by citations

Items 801–900 of 1,000

Herceptin, a recombinant humanized anti-ERBB2 monoclonal antibody, induces cardiomyocyte death
Singh, K. K., Shukla, P. C., Quan, A., Lovren, F., Pan, Y., Wolfstadt, J. I., Gupta, M., Al-Omran, M. A., Leong-Poi, H. M., Teoh, H., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.06.169 · Cited by 21
Therapeutic targeting of the p53 tumor suppressor gene
Beaudry, G. A. (1996) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(96)80069-3 · Cited by 21
Protecting the genome from mdm2 and mdmx
Melo, A. N., & Eischen, C. M. (2012) · Genes & Cancer · doi:10.1177/1947601912454139 · Cited by 20
Inhibition of AKT/FoxO3a signaling induced PUMA expression in response to p53-independent cytotoxic effects of H1: A derivative of tetrandrine
Zhang, Y.-X., Liu, X., Wang, J., Li, J., Liu, Y., Zhang, H., Yu, X., & Wei, N. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1040950 · Cited by 20
MDM2 SNP285 does not antagonize the effect of SNP309 in lung cancer
Ryan, B. M., Calhoun, K. M., Pine, S. R., Bowman, E. D., Robles, A. I., Ambs, S., & Harris, C. C. (2012) · International Journal of Cancer · doi:10.1002/ijc.27573 · Cited by 20
The Potential of Targeting P53 and HSP90 Overcoming Acquired MAPKi-Resistant Melanoma
Hsieh, C., & Shen, C. (2019) · Current Treatment Options in Oncology · doi:10.1007/s11864-019-0622-9 · Cited by 20
p53 Antibodies as a Diagnostic Marker for Cancer: A Meta-Analysis
Sobhani, N., Roviello, G., D’Angelo, A., Roudi, R., Neeli, P. K., & Generali, D. (2021) · Molecules · doi:10.3390/molecules26206215 · Cited by 20
Tissue specificity and spatio-temporal dynamics of the p53 transcriptional program
Pant, V., Sun, C., & Lozano, G. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01123-2 · Cited by 21
MDM2 inhibitors in cancer immunotherapy: Current status and perspective
Zeng, Q., Zeng, S., Dai, X., Ding, Y., Huang, C., Ruan, R., Xiong, J., Tang, X., & Deng, J. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2024.101279 · Cited by 20
Ubiquitin Ligases in Cancer: Ushers for Degradation
Newton, K., & Vucic, D. (2007) · Cancer Investigation · doi:10.1080/07357900701508041 · Cited by 20
O-linked N-acetylglucosamine transferase (OGT) is overexpressed and promotes O-linked protein glycosylation in esophageal squamous cell carcinoma
Qiao, Z., Cheng-xue, D., Zhou, B., Li, S., Zhang, W., Jian-tao, J., Zhang, J., Ranran, K., & Ma, Y. (2012) · Journal of Biomedical Research · doi:10.7555/jbr.26.20110121 · Cited by 20
MDM2 knockdown mediated by a triazine-modified dendrimer in the treatment of non-small cell lung cancer
Huang, Q., Li, L., Li, L., Chen, H., Dang, Y., Zhang, J., Shao, N., Chang, H., Zhou, Z., Liu, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.9768 · Cited by 20
Mouse modelling of the MDM2/MDMX−p53 signalling axis
Tackmann, N. R., & Zhang, Y. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx006 · Cited by 21
MDM2 and mitochondrial function: One complex intersection
Rubio‐Patiño, C., Trotta, A. P., & Chipuk, J. E. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.10.032 · Cited by 20
p53 Activation in Genetic Disorders: Different Routes to the Same Destination
Tsai, Y.-Y., Su, C.-H., & Tarn, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179307 · Cited by 21
MDM2-A, a common Mdm2 splice variant, causes perinatal lethality, reduced longevity and enhanced senescence
Volk, E. L., Schuster, K., Nemeth, K. M., Fan, L., & Harris, L. C. (2008) · Disease Models & Mechanisms · doi:10.1242/dmm.000992 · Cited by 20
High Expression of Human Homologue of Murine Double Minute 4 and the Short Splicing Variant, HDM4-S, in Bone Marrow in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Han, X., Medeiros, L. J., Zhang, Y. H., You, M. J., Andreeff, M., Konopleva, M. Y., & Bueso-Ramos, C. (2016) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2016.03.012 · Cited by 19
The p53 Tumor Suppressor Pathway and Cancer
Zambetti, G. P. (2005) · Springer eBooks · doi:10.1007/0-387-30127-5 · Cited by 20
Organization, expression, and localization of the murine mdmx gene and pseudogene
Parant, J. M., Reinke, V., Mims, B. H., & Lozano, G. (2001) · Gene · doi:10.1016/s0378-1119(01)00432-2 · Cited by 20
Cellular and organismal ageing: Role of the p53 tumor suppressor protein in the induction of transient and terminal senescence
Schmid, G., Kramer, M. P., Maurer‐Granofszky, M., Wandl, S., & Węsierska‐Gądek, J. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21383 · Cited by 20
Stromal-MDM2 Promotes Lung Cancer Cell Invasion through Tumor–Host Feedback Signaling
Kamer, I., Daniel‐Meshulam, I., Zadok, O., Bab-Dinitz, E., Perry, G., Feniger-Barish, R., Perelman, M., Barshack, I., Ben‐Nun, A., Onn, A., et al. (2020) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0395 · Cited by 19
Synthesis and Biological Evaluation of Novel Dispiro-Indolinones with Anticancer Activity
Ivanenkov, Y. A., Kukushkin, M. E., Beloglazkina, A. A., Shafikov, R. R., Barashkin, A. A., Ayginin, A. A., Serebryakova, M. S., Majouga, A. G., Skvortsov, D. A., Тафеенко, В. А., et al. (2023) · Molecules · doi:10.3390/molecules28031325 · Cited by 19
Jmjd5 functions as a regulator of p53 signaling during mouse embryogenesis
Ishimura, A., Terashima, M., Tange, S., & Suzuki, T. (2015) · Cell and Tissue Research · doi:10.1007/s00441-015-2276-7 · Cited by 19
p37Ing1b Regulates B-Cell Proliferation and Cooperates with p53 to Suppress Diffuse Large B-Cell Lymphomagenesis
Coles, A. H., Marfella, C. G. A., Imbalzano, A. N., Steinman, H. A., Garlick, D. S., Gerstein, R. M., & Jones, S. N. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0923 · Cited by 22
Self-citation
Mdm2 overexpression and p73 loss exacerbate genomic instability and dampen apoptosis, resulting in B-cell lymphoma
Riley, M. F., You, M. J., Multani, A. S., & Lozano, G. (2015) · Oncogene · doi:10.1038/onc.2015.88 · Cited by 19
Mouse models of Mdm2 and Mdm4 and their clinical implications
Xiong, S. (2013) · 癌症：英文版 · doi:10.5732/cjc.012.10286 · Cited by 19
MDM2 controls gene expression independently of p53 in both normal and cancer cells
Arena, G., Riscal, R., Linares, L. K., & Cam, L. L. (2018) · Cell Death and Differentiation · doi:10.1038/s41418-018-0156-x · Cited by 19
Transcriptional repressor NIR interacts with the p53-inhibiting ubiquitin ligase MDM2
Heyne, K., Förster, J., Schüle, R., & Roemer, K. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1371 · Cited by 19
New targets for the treatment of follicular lymphoma
Tageja, N., Padheye, S., Dandawate, P. R., Al-Katib, A. M., & Mohammad, R. M. (2009) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-2-50 · Cited by 20
Additive effect of adenovirus-mediated E2F-1 gene transfer and topoisomerase II inhibitors on apoptosis in human osteosarcoma cells
Yang, H. L., Dong, Y., Elliott, M. J., Wong, S. L., & McMasters, K. M. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700301 · Cited by 19
Targeting HAUSP in both p53 wildtype and p53-mutant tumors
Tavana, O., Sun, H., & Gu, W. J. (2018) · Cell Cycle · doi:10.1080/15384101.2018.1456293 · Cited by 20
Screening of Pleural Mesotheliomas for DNA-damage Repair Players by Digital Gene Expression Analysis Can Enhance Clinical Management of Patients Receiving Platin-Based Chemotherapy
Walter, R. F. H., Vollbrecht, C., Werner, R., Mairinger, T., Schmeller, J., Flom, E., Wohlschlaeger, J., Barbetakis, N. G., Paliouras, D., Chatzinikolaou, F. G., et al. (2016) · Journal of Cancer · doi:10.7150/jca.16390 · Cited by 18
Unmasking the biological function and regulatory mechanism of NOC2L: a novel inhibitor of histone acetyltransferase
Lu, S., Chen, K., Liu, Z., & Liu, Z. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03877-2 · Cited by 18
Contrasting effects of an Mdm2 functional polymorphism on tumor phenotypes
Ortiz, J., Li, Y., Post, S. M., Pant, V., Xiong, S., Larsson, C. A., El‐Naggar, A. K., Johnson, D. G., & Lozano, G. (2017) · Oncogene · doi:10.1038/onc.2017.344 · Cited by 18
X-Linked Huwe1 Is Essential for Oocyte Maturation and Preimplantation Embryo Development
Eisa, A. A., Bang, S., Crawford, K. J., Murphy, E. M., Feng, W. W., Dey, S., Wells, W. A., Kon, N., Gu, W. J., Mehlmann, L. M., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101523 · Cited by 18
Cell Death and the p53 Enigma During Mammalian Embryonic Development
Raj, S., Jaiswal, S. K., & Depamphilis, M. (2022) · Stem Cells · doi:10.1093/stmcls/sxac003 · Cited by 24
Bromoetherification-based strategy towards the spirocyclic chromophore of chlorofusin
Wei, W., Qian, W., Zhang, Y., & Yao, Z. (2006) · Tetrahedron Letters · doi:10.1016/j.tetlet.2006.04.062 · Cited by 23
MDM2 gene amplification and protein expressions in colon carcinoma: is targeting MDM2 a new therapeutic option?
Hav, M., Libbrecht, L. J., Ferdinande, L., Pattyn, P., Laurent, S., Peeters, M., Praet, M. M., & Pauwels, P. (2010) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-010-1012-7 · Cited by 18
Selective protein degradation in cell signalling
Liu, H., Urbé, S., & Clague, M. J. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.01.014 · Cited by 17
Developmental noise, ageing and cancer
Aranda‐Anzaldo, A., & Dent, M. A. R. (2003) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(03)00089-7 · Cited by 18
Epstein-Barr virus infection and mitogen stimulation of normal B cells induces wild-type p53 without subsequent growth arrest or apoptosis.
Tamm, K. P., Okan, İ., Kashuba, E., L√∂wbeer, M., Klein, G., & Székely, L. (1999) · Journal of General Virology · doi:10.1099/0022-1317-80-4-987 · Cited by 18
Deletion of p21 cannot substitute for p53 loss in rescue of mdm2 null lethality
Luna, R. M. D. O., Amelse, L. L., Chávez‐Reyes, A., Evans, S. C., Brugarolas, J., Jacks, T., & Lozano, G. (1997) · Nature Genetics · doi:10.1038/ng0897-336 · Cited by 18
Protein of a thousand faces: The tumor-suppressive and oncogenic responses of p53
Marques, M. A., de Andrade, G. C., Silva, J. L., & de Oliveira, G. A. P. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.944955 · Cited by 16
Harnessing p53 for targeted cancer therapy: new advances and future directions
Andrysík, Z., & Espinosa, J. M. (2025) · Transcription · doi:10.1080/21541264.2025.2452711 · Cited by 19
MDM2 oligomers: antagonizers of the guardian of the genome
Leslie, P. L., & Zhang, Y. (2016) · Oncogene · doi:10.1038/onc.2016.88 · Cited by 18
Inhibition of Mdmx (Mdm4) in vivo induces anti-obesity effects
Kon, N., Wang, D., Li, T., Jiang, L., Qiang, L., & Gu, W. (2018) · Oncotarget · doi:10.18632/oncotarget.23837 · Cited by 17
E3 ubiquitin ligase MDM2 acts through p53 to control respiratory progenitor cell number and lung size
Sui, P., Li, R., Zhang, Y., Tan, C., Garg, A., Verheyden, J. M., & Sun, X. (2019) · Development · doi:10.1242/dev.179820 · Cited by 17
Bibenzyl analogue DS-1 inhibits MDM2-mediated p53 degradation and sensitizes apoptosis in lung cancer cells
Putri, H. E., Nutho, B., Rungrotmongkol, T., Sritularak, B., Vinayanuwattikun, C., & Pithi Chanvorachote, B. (2021) · Phytomedicine · doi:10.1016/j.phymed.2021.153534 · Cited by 17
MDM2 Overexpression, Activation of Signaling Networks, and Cell Proliferation
Deb, S. P., Singh, S., & Deb, S. (2014) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-94-017-9211-0_12 · Cited by 18
Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection
Yang, H., Zheng, Z., Zhao, L., Li, Q., & Liao, D. (2012) · Cell Cycle · doi:10.4161/cc.11.3.19052 · Cited by 18
The Lethality of Ku86 (XRCC5) Loss-of-Function Mutations in Human Cells is Independent of p53 (TP53)
Ghosh, G., Li, G., Myung, K., & Hendrickson, E. A. (2007) · Radiation Research · doi:10.1667/rr0692.1 · Cited by 17
Loss of oocytes due to conditional ablation of Murine double minute 2 (Mdm2) gene is p53‐dependent and results in female sterility
Livera, G., Uzbekov, R. E., Jarrier-Gaillard, P., Fouchécourt, S., Duquenne, C., Parent, A., Marine, J., & Monget, P. (2016) · FEBS Letters · doi:10.1002/1873-3468.12275 · Cited by 17
Indispensable role of Mdm2/p53 interaction during the embryonic and postnatal inner ear development
Laos, M., Sulg, M., Herranen, A., Anttonen, T., & Pirvola, U. (2017) · Scientific Reports · doi:10.1038/srep42216 · Cited by 17
Mouse models with modified p53 sequences to study cancer and ageing
Clarke, A. R., & Hollstein, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401188 · Cited by 17
MTBP and MYC: A Dynamic Duo in Proliferation, Cancer, and Aging
Grieb, B. C., & Eischen, C. M. (2022) · Biology · doi:10.3390/biology11060881 · Cited by 18
Liver‐specific expression of p53‐negative regulator mdm2 leads to growth retardation and fragile liver in zebrafish
Chen, L.-J., Hsu, C., Hong, J., Jou, L.-K., Tseng, H., Wu, J., Liou, Y., & Her, G. M. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21477 · Cited by 16
Expanding the horizon of chemotherapeutic targets: From MDM2 to MDMX (MDM4)
Macchiarulo, A., Giacchè, N., Carotti, A., Moretti, F., & Pellicciari, R. (2011) · MedChemComm · doi:10.1039/c0md00238k · Cited by 16
microRNAs are differentially regulated between MDM2-positive and negative malignant pleural mesothelioma
Walter, R. F. H., Vollbrecht, C., Werner, R., Wohlschlaeger, J., Christoph, D. C., Schmid, K. W., & Mairinger, F. D. (2016) · Oncotarget · doi:10.18632/oncotarget.7666 · Cited by 16
A Single Conserved Amino Acid Residue as a Critical Context-Specific Determinant of the Differential Ability of Mdm2 and MdmX RING Domains to Dimerize
Kosztyu, P., Slaninová, I., Valčíková, B., Verlande, A., Müller, P., Palecek, J. J., & Uldrijan, S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00390 · Cited by 15
Mdm2 and MdmX RING Domains Play Distinct Roles in the Regulation of p53 Responses: A Comparative Study of Mdm2 and MdmX RING Domains in U2OS Cells
Egorova, O., Lau, H. H., McGraphery, K., & Sheng, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041309 · Cited by 17
Interaction between p53 Mutation and a Somatic HDMX Biomarker Better Defines Metastatic Potential in Breast Cancer
Grawenda, A. M., Møller, E. K., Lam, S., Repapi, E., Teunisse, A. F. A. S., Alnæs, G. I. G., Børresen‐Dale, A., Kristensen, V. N., Goding, C. R., Jochemsen, A. G., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2637 · Cited by 16
Mdm2 mediates FMRP- and Gp1 mGluR-dependent protein translation and neural network activity
Liu, D.-C., Seimetz, J. W., Lee, K. Y., Kalsotra, A., Chung, H. J., Lu, H., & Tsai, N. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx276 · Cited by 19
Expression of mdm2 and p53 in epithelial neoplasms of the colorectum
Hao, X., Gunther, T., Roessner, A., Price, A. B., & Talbot, I. C. (1998) · Molecular Pathology · doi:10.1136/mp.51.1.26 · Cited by 16
Knocking down PML impairs p53 signaling transduction pathway and suppresses irradiation induced apoptosis in breast carcinoma cell MCF‐7
Bao‐Lei, T., Zhuzhong, M., Song, Y., Jun‐Jie, Q., Yan, D., Hua, L., Bin, L., Zhao, G., & Zhi‐Xian, S. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20584 · Cited by 16
Oncogenic functions of hMDMX in in vitro transformation of primary human fibroblasts and embryonic retinoblasts
Lenos, K., de Lange, J., Teunisse, A. F., Lodder, K., Verlaan-de Vries, M., Wiercinska, E., van der Burg, M. J., Szuhai, K., & Jochemsen, A. G. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-111 · Cited by 16
“The importance of MDM2 in p53 regulation was best shown by the p53-dependent embryonic lethality of MDM2 -/- mice [7,8].”
Background
What do we need to know and understand about p53 to improve its clinical value?
Salomao, N., Karakostis, K., Hupp, T., Vollrath, F., Vojtesek, B., & Fahraeus, R. (2021) · The Journal of Pathology · doi:10.1002/path.5677 · Cited by 15
MLF2 Negatively Regulates P53 and Promotes Colorectal Carcinogenesis
Fang, D., Hu, H. Q., Zhao, K., Xu, A., Yu, C., Zhu, Y., Yu, N., Yao, B., Tang, S., Wu, X., et al. (2023) · Advanced Science · doi:10.1002/advs.202303336 · Cited by 14
Small-Molecule Approaches to Target Transcription Factors
Cui, H., Stilgenbauer, M., & Koehler, A. N. (2024) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-062722-012209 · Cited by 19
Arrestins in Apoptosis
Kook, S., Gurevich, V. V., & Gurevich, E. V. (2013) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-41199-1_16 · Cited by 15
Association of the MDM2 SNP285 and SNP309 Genetic Variants with the Risk, Age at Onset and Prognosis of Breast Cancer in Central European Women: A Hospital-Based Case-Control Study
Miedl, H., Lebhard, J., Ehart, L., & Schreiber, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030509 · Cited by 14
The Janus Face of p53-Targeting Ubiquitin Ligases
Hao, Q., Chen, Y., & Zhou, X. Y. (2020) · Cells · doi:10.3390/cells9071656 · Cited by 16
Glutathione and p53 independently mediate responses against oxidative stress in ES cells
Coe, J. P., Rahman, I., Sphyris, N., Clarke, A. R., & Harrison, D. J. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00792-4 · Cited by 15
Blastocyst-Derived Stem Cell Populations under Stress: Impact of Nutrition and Metabolism on Stem Cell Potency Loss and Miscarriage
Yang, Y., Bolnick, A. D., Shamir, A. M., Abdulhasan, M. A., Li, Q., Parker, G. C., Puscheck, E. E., & Rappolee, D. A. (2017) · Stem Cell Reviews and Reports · doi:10.1007/s12015-017-9734-4 · Cited by 15
SRC Increases MYC mRNA Expression in Estrogen Receptor-Positive Breast Cancer via mRNA Stabilization and Inhibition of p53 Function
Abdullah, C., Körkaya, H., Iizuka, S., & Courtneidge, S. A. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00463-17 · Cited by 15
Dissection of the functional interaction between p53 and the embryonic proto‐oncoprotein PAX3
Underwood, T., Amin, J., Lillycrop, K. A., & Blaydes, J. P. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.056 · Cited by 15
A modified p53 overcomes mdm2-mediated oncogenic transformation: a potential cancer therapeutic agent.
Lin, J., Jin, X., Page, C., Sondak, V. K., Jiang, G., & Reynolds, R. K. (2000) · PubMed · Cited by 15
Disrupting the p53-mdm2 interaction as a potential therapeutic modality
Moll, U. M., & Zaika, A. (2000) · Drug Resistance Updates · doi:10.1054/drup.2000.0160 · Cited by 15
Bivalent binding of p14ARF to MDM2 RING and acidic domains inhibits E3 ligase function
Kowalczyk, D., Nakasone, M. A., Smith, B. O., & Huang, D. T. C. (2022) · Life Science Alliance · doi:10.26508/lsa.202201472 · Cited by 15
Generation of an Mdm2 conditional allele in mice
Steinman, H. A., & Jones, S. N. (2002) · genesis · doi:10.1002/gene.10035 · Cited by 14
Self-citation
Daxx Functions Are p53-Independent In Vivo
Wasylishen, A. R., Estrella, J. S., Pant, V., Chau, G. P., & Lozano, G. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-18-0281 · Cited by 14
Regulation of p53 and NF-κB transactivation activities by DGKζ in catalytic activity-dependent and -independent manners
Tanaka, T., Nakano, T., Hozumi, Y., Martelli, A. M., & Goto, K. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.118953 · Cited by 15
OSU-03012, a non-cox inhibiting celecoxib derivative, induces apoptosis of human esophageal carcinoma cells through a p53/Bax/cytochrome c/caspase-9-dependent pathway
Liu, J., Qin, C., Lv, W., Zhao, Q., & Qin, C. (2013) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328362469f · Cited by 14
The Zn-finger domain of MdmX suppresses cancer progression by promoting genome stability in p53-mutant cells
Matijašević, Z., Krzywicka-Racka, A., Sluder, G., Gallant, J., & Jones, S. N. (2016) · Oncogenesis · doi:10.1038/oncsis.2016.62 · Cited by 14
Self-citation
MDM2 Protein Overexpression Inhibits Apoptosis of TF-1 Granulocyte-Macrophage Colony-Stimulating Factor–Dependent Acute Myeloblastic Leukemia Cells
Urashima, M., Teoh, G. K. H., Chauhan, D., Ogata, A., Shirahama, S., Kaihara, C., Matsuzaki, M., Matsushima, H., Akiyama, M., Yuza, Y., et al. (1998) · Blood · doi:10.1182/blood.v92.3.959 · Cited by 14
The role of the ubiquitination-proteasome pathway in breast cancer: Use of mouse models for analyzing ubiquitination processes
Rossi, S., & Loda, M. F. (2002) · Breast Cancer Research · doi:10.1186/bcr542 · Cited by 14
Broadly expressed tumour?associated proteins as targets for cytotoxic T lymphocyte-based cancer immunotherapy
Bendle, G. M., Holler, A., Downs, A.-M., Xue, S., & Stauss, H. J. (2005) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.5.9.1183 · Cited by 14
The TP53 signaling network in mammals and worms
Jolliffe, A. K., & Derry, W. B. (2012) · Briefings in Functional Genomics · doi:10.1093/bfgp/els047 · Cited by 14
p53-dependent apoptosis and transcription of p21waf/cip1/sdi1 in SCID mice following γ-irradiation
Candéias, S. M., Durum, S. K., & Muegge, K. (1997) · Biochimie · doi:10.1016/s0300-9084(97)82010-x · Cited by 14
ER stress-induced modulation of neural activity and seizure susceptibility is impaired in a fragile X syndrome mouse model
Liu, D.-C., Lee, K. Y., Lizarazo, S., Cook, J. K., & Tsai, N. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105450 · Cited by 15
MDMX Regulates Transcriptional Activity of p53 and FOXO Proteins to Stimulate Proliferation of Melanoma Cells
Heijkants, R. C., Teunisse, A. F. A. S., de Jong, D., Glinkina, K., Mei, H., Kiełbasa, S. M., Szuhai, K., & Jochemsen, A. G. (2022) · Cancers · doi:10.3390/cancers14184482 · Cited by 13
Thymine DNA glycosylase regulates cell-cycle-driven p53 transcriptional control in pluripotent cells
Aranda, S., Alcaine-Colet, A., Ballaré, C., Blanco, E., Mocavini, I., Sparavier, A., Vizán, P., Borràs, E., Sabidó, E., & Croce, L. D. (2023) · Molecular Cell · doi:10.1016/j.molcel.2023.07.003 · Cited by 14
Targeting the conformational transitions of MDM2 and MDMX: Insights into key residues affecting p53 recognition
Carotti, A., Macchiarulo, A., Giacchè, N., & Pellicciari, R. (2009) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.22464 · Cited by 13
Novel INHAT Repressor (NIR) is required for early lymphocyte development
Ma, C. A., Pusso, A., Wu, L., Zhao, Y., Hoffmann, V. J., Notarangelo, L. D., Fowlkes, B. J., & Jain, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310118111 · Cited by 13
Cerebellum Development and Tumorigenesis: A p53-Centric Perspective
Barthelery, N. J., & Manfredi, J. J. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.03.006 · Cited by 13
Inhibition of MDM2 via Nutlin-3A: A Potential Therapeutic Approach for Pleural Mesotheliomas with MDM2-Induced Inactivation of Wild-Type P53
Walter, R. F. H., Werner, R., Wessolly, M., Mairinger, E., Borchert, S., Schmeller, J., Kollmeier, J., Mairinger, T., Hager, T., Bánkfalvi, Á., et al. (2018) · Journal of Oncology · doi:10.1155/2018/1986982 · Cited by 13
DNA replication in progenitor cells and epithelial regeneration after lung injury requires the oncoprotein MDM2
Singh, S., Vaughan, C. A., Rabender, C. S., Mikkelsen, R. B., Deb, S., & Deb, S. P. (2019) · JCI Insight · doi:10.1172/jci.insight.128194 · Cited by 13
A Survey of Essential Genome Stability Genes Reveals That Replication Stress Mitigation Is Critical for Peri-Implantation Embryogenesis
Kafer, G. R., & Cesare, A. J. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00416 · Cited by 12
A p53-Dependent Checkpoint Induced upon DNA Damage Alters Cell Fate during hiPSC Differentiation
Eldridge, C. B., Allen, F. J., Crisp, A., Grandy, R. A., Vallier, L., & Sale, J. E. (2020) · Stem Cell Reports · doi:10.1016/j.stemcr.2020.08.003 · Cited by 13
The RNA binding protein RALY suppresses p53 activity and promotes lung tumorigenesis
Hu, H., Zhao, K., Fang, D., Wang, Z., Yu, N., Yao, B., Liu, K., Wang, F., & Mei, Y. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112288 · Cited by 13
The mechanisms of regulation of Hdm2 protein level by serum growth factors
Phillips, A., Jones, C. J., & Blaydes, J. P. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.12.026 · Cited by 13

Authors: Jones, S. N., Roe, A. E., Donehower, L. A., & Bradley, A.
Affiliations: Howard Hughes Medical Institute (US)
Baylor College of Medicine (US)
ORCID: Bradley, Allan
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 1995-11
Volume: 378
Issue: 6553
Pages: 206-208
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/378206a0
OpenAlex: W1993864973
Semantic Scholar: efc84bf5f5d1747443a3eb4555f9b5ede31b368f
Cited by: 1,280
References: 24
Citations by year: 2026: 9 · 2025: 17 · 2024: 30 · 2023: 31 · 2022: 28 · 2021: 35 · 2020: 41 · 2019: 28 · 2018: 31 · 2017: 38 · 2016: 54 · 2015: 34 · 2014: 59 · 2013: 30 · 2012: 60
FWCI: 14.50
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords: MDM2, p53, embryonic lethality, developmental regulation, tumor suppressor, sarcoma, leukemia
MeSH terms: Proto-Oncogene Mas, Animals, Base Sequence, Cell Cycle, Cell Line, Crosses, Genetic, Female, Embryonic and Fetal Development, Genes, Lethal, Molecular Sequence Data, Mutation, Nuclear Proteins, Proto-Oncogene Proteins, Tumor Suppressor Protein p53, 3T3 Cells, DNA Primers, Gene Targeting, Mice, Proto-Oncogene Proteins c-mdm2

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Rescue of embryonic lethality in Mdm2-deficient mice by absence of p53

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks